The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
The Effects of Inhaled Iloprost on Congenital Heart Disease With Eisenmenger Syndrome
Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the
 evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted
 therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess
 the effects of inhaled iloprost on patients with Eisenmenger's syndrome.
Inclusion Criteria:

 -  patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization

 Exclusion Criteria: